Trials / Completed
CompletedNCT04069078
Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section
Prophylactic Use of Iv Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section Under Spinal Anaesthesia. a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the efficacy of Iv hyoscine butylbromide in preventing Bradycardia during cesarean section under spinal anaesthesia with local anaesthetic and morphine.
Conditions
- Bradycardia
- Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
- Cesarean Section Complications
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyoscine Butylbromide 20 Mg/mL Solution for Injection Ampoule | Patients will receive IV study solution which is hyoscine butylbromide 20 mg in 1 ml one minute after spinal anaesthesia |
| OTHER | Normal saline | Patients will receive 1 ml of IV normal saline as a placebo one minute after spinal anesthesia |
Timeline
- Start date
- 2019-10-10
- Primary completion
- 2020-02-25
- Completion
- 2020-02-25
- First posted
- 2019-08-28
- Last updated
- 2020-03-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04069078. Inclusion in this directory is not an endorsement.